STARPHARMA HOLDINGS LTD TO ACQUIRE DENDRITIC NANOTECHNOLOGIES LIMITED FOR $6.97 MILLION

Starpharma Holdings Limited announced the signing of an agreement to acquire US-based Dendritic Nanotechnologies, Inc. (DNT) for US$6.97m (A$9.36m) payable through the issue of Starpharma shares. BioSpace (http://www.biospace.com/news_story.aspx?StoryID=32089&full=1)